332 related articles for article (PubMed ID: 7901681)
1. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Leung DY; Meissner HC; Fulton DR; Murray DL; Kotzin BL; Schlievert PM
Lancet; 1993 Dec; 342(8884):1385-8. PubMed ID: 7901681
[TBL] [Abstract][Full Text] [Related]
2. Superantigenic exotoxin production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children.
Todome Y; Ohkuni H; Mizuse M; Okibayashi F; Ohtani N; Suzuki H; Song C; Igarashi H; Harada K; Sakurai S
J Med Microbiol; 1995 Feb; 42(2):91-5. PubMed ID: 7869353
[TBL] [Abstract][Full Text] [Related]
3. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
Leung DY; Sullivan KE; Brown-Whitehorn TF; Fehringer AP; Allen S; Finkel TH; Washington RL; Makida R; Schlievert PM
Pediatr Res; 1997 Sep; 42(3):268-72. PubMed ID: 9284264
[TBL] [Abstract][Full Text] [Related]
4. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
Leung DY; Meissner C; Fulton D; Schlievert PM
J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.
Leung DY; Meissner HC; Shulman ST; Mason WH; Gerber MA; Glode MP; Myones BL; Wheeler JG; Ruthazer R; Schlievert PM
J Pediatr; 2002 Jun; 140(6):742-6. PubMed ID: 12072880
[TBL] [Abstract][Full Text] [Related]
6. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome.
Nomura Y; Yoshinaga M; Masuda K; Takei S; Miyata K
J Infect Dis; 2002 Jun; 185(11):1677-80. PubMed ID: 12023778
[TBL] [Abstract][Full Text] [Related]
7. [Clinical aspects of streptococcal and staphylococcal toxinic diseases].
Floret D
Arch Pediatr; 2001 Sep; 8 Suppl 4():762s-768s. PubMed ID: 11582925
[TBL] [Abstract][Full Text] [Related]
8. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
Rowley AH; Shulman ST
Pediatr Res; 1998 Feb; 43(2):291-3. PubMed ID: 9475299
[No Abstract] [Full Text] [Related]
9. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus.
Hall M; Hoyt L; Ferrieri P; Schlievert PM; Jenson HB
Clin Infect Dis; 1999 Sep; 29(3):586-9. PubMed ID: 10530452
[TBL] [Abstract][Full Text] [Related]
10. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease.
Terai M; Miwa K; Williams T; Kabat W; Fukuyama M; Okajima Y; Igarashi H; Shulman ST
J Infect Dis; 1995 Aug; 172(2):558-61. PubMed ID: 7622905
[TBL] [Abstract][Full Text] [Related]
11. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
Smith RJ; Schlievert PM; Himelright IM; Baddour LM
Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
Park JY; Kim JS; Woo H
Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies of toxic shock toxin-1-secreting Staphylococcus aureus and implications for burn care in children.
Laabei M; Young A; Jenkins TA
Pediatr Infect Dis J; 2012 May; 31(5):e73-7. PubMed ID: 22301473
[TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Curtis N; Chan B; Levin M
Lancet; 1994 Jan; 343(8892):299. PubMed ID: 7905127
[No Abstract] [Full Text] [Related]
15. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
[TBL] [Abstract][Full Text] [Related]
16. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
[TBL] [Abstract][Full Text] [Related]
17. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease.
Matsubara K; Fukaya T
Curr Opin Infect Dis; 2007 Jun; 20(3):298-303. PubMed ID: 17471041
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.
Wann ER; Fehringer AP; Ezepchuk YV; Schlievert PM; Bina P; Reiser RF; Höök MM; Leung DY
Infect Immun; 1999 Sep; 67(9):4737-43. PubMed ID: 10456925
[TBL] [Abstract][Full Text] [Related]
19. Purpura fulminans due to Staphylococcus aureus.
Kravitz GR; Dries DJ; Peterson ML; Schlievert PM
Clin Infect Dis; 2005 Apr; 40(7):941-7. PubMed ID: 15824983
[TBL] [Abstract][Full Text] [Related]
20. Cytolysins augment superantigen penetration of stratified mucosa.
Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
